環形戒指市場：現況分析與預測（2023-2030）

由於易患心臟瓣膜疾病的老年人口增加，瓣環成形環市場預計將以約3.53%的速度穩定成長。 例如，根據世界衛生組織(WHO)稱，到2050年，全球60歲以上人口將翻一番，達到21億。 此外，2020 年至 2050 年間，80 歲及以上的人口數量預計將增加兩倍，達到 4.26 億。 心臟病盛行率急劇上升、人們對心血管疾病的認識不斷提高以及對心臟病學投資的增加等幾個因素正在推動預測期內的市場成長。 除此之外，瓣環成形環提高了治療效率，從而加快了治療過程並提高了準確性，這也穩步推動了瓣環成形環市場的發展。

市場依剛性分為柔性、剛性、半剛性等。 到 2022 年，剛性部分將在細分市場中佔據最大份額，因為它為二尖瓣提供穩定性。 剛性瓣環成形術環是用於心臟手術，特別是二尖瓣修復的裝置。 這些環旨在支撐和重塑二尖瓣環，二尖瓣環是圍繞瓣膜的纖維環。 由於冠心病和高血壓患者數量不斷增加，該細分市場佔據了市場主導地位。 例如，心臟病家族史也是該細分市場的驅動因素。 因此，在剛性類型中，剛性環細分市場將在2022年佔據很大的市場份額。

依應用，市場分為二尖瓣成形術、三尖瓣成形術、主動脈瓣成形術等。 由於三尖瓣逆流的盛行率不斷上升，預計三尖瓣成形術領域在預測期內將佔據相當大的市場份額。 例如，根據Science Direct 2023 年10 月報道，中度或重度三尖瓣逆流（TR）的發生率隨著年齡的增長而增加，在一般人群中男性患病率達到1.5%，女性患病率達到5.6%。 三尖瓣瓣環成形術用於解決三尖瓣逆流 (TR) 等疾病，即心臟收縮時血液回流到右心房。 因此，應用中的三尖瓣成形術類別在預測期內將表現出較高的複合年增長率。

為了更了解環生環的市場介紹，我們根據其在北美、歐洲、亞太地區和世界其他地區的全球影響力對市場進行了分析。 截至 2022 年，由於老年人口不斷增長以及開發有效環形形成環的投資不斷增加，北美將主導市場。 例如，根據人口研究所的數據，65 歲及以上的美國人數量預計將從 2022 年的 5,800 萬增加到 2050 年的 8,200 萬（增加 47%）。 政府機構已啟動心臟病意識計劃，為患者提供有效的治療。 除此之外，北美還擁有眾多領先的醫療器材製造商，進一步推動了該地區環形塑膠環市場的成長。

該市場的主要參與者包括 Affluence Medical、Corcym、Braile Biomedica、Coronaneo、Edwards Lifesciences Corporation、Genesee BioMedical、HVR Cardio Oy、Medtronic、Abbott 和 Valcare Medical。

目錄

第1章市場介紹

• 市場定義
• 主要目標
• 利害關係人
• 限制

第2章研究方法或前提

• 調查過程
• 調查方法
• 受訪者簡介

第3章市場總結

第 4 章執行摘要

第五章 COVID-19 對環形戒指市場的影響

第六章環形形成環市場收入（2020-2030）

第 7 章市場洞察：剛性

• 靈活
• 剛性
• 半剛性
• 其他

第 8 章市場洞察：按應用劃分

• 二尖瓣環成形術
• 三尖瓣環成形術
• 主動脈瓣環成形術
• 其他

第 9 章市場洞察：按地區

• 北美
  • 美國
  • 加拿大
  • 北美其他地區
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 亞太地區其他地區
• 世界其他地區

第10章瓣環成形環市場動態

• 市場驅動因素
• 市場挑戰
• 影響分析

第11章瓣環成形環市場機會

第12章瓣環成形環市場趨勢

第13章需求方與供給方分析

• 需求方分析
• 供給面分析

第14章價值鏈分析

第15章競爭場景

• 競爭狀況
  • 波特五力分析

第16章公司簡介

• Affluent Medical
• Corcym
• Braile Biomedica
• Coroneo
• Edwards Lifesciences Corporation
• Genesee BioMedical
• HVR Cardio Oy
• Medtronic
• Abbott
• Valcare Medical

第17章 免責事項

Annuloplasty rings are devices used in cardiac surgery to treat mitral or tricuspid valve insufficiency. These rings are typically made of durable materials like titanium or polymers and are placed around the heart valve's annulus-the fibrous ring surrounding the valve leaflets. The primary purpose of annuloplasty rings is to restore the proper shape and size of the valve annulus, ensuring optimal valve function. They help in correcting valve regurgitation by providing structural support and preventing further dilation of the annulus. Annuloplasty rings have been gaining popularity in the market owing to several factors, such as increasing incidence of heart valve disorders, advancements in technology, growing minimally invasive procedures, increasing awareness and diagnosis, rising healthcare expenditure, rising regulatory support, and surge in company collaborations & partnerships are leading drivers of annuloplasty rings globally.

The Annuloplasty Rings Market is expected to grow at a steady rate of around 3.53% owing to the rising geriatric population which is more sensitive towards heart valve disorders. For instance, according to the World Health Organization, by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. The population of number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Several factors, including a surge in the incidence of cardiac disorders, increasing awareness regarding cardiovascular disorders, and increased investments in cardiology departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with annuloplasty rings has resulted in faster treatment procedures and better accuracy which is also driving this market of annuloplasty rings at a steady rate.

Based on rigidity, the market is segmented into flexible, rigid, semi-rigid, and others. The rigid segment held the maximum share in the global market of annuloplasty rings in 2022 owing to the stability it provides to the mitral valve. Rigid annuloplasty rings are devices used in cardiac surgery, particularly in mitral valve repair procedures. These rings are designed to support and reshape the mitral valve annulus, which is the fibrous ring surrounding the valve. This segment dominated the market because of the rising cases of coronary heart disease and high blood pressure. For instance, A family history of heart disease is also a propelling factor for this segment. Thus, among the rigidity type, the rigid ring segment held a significant share of the market in 2022.

Based on application, the market is categorized into mitral valve annuloplasty, tricuspid valve annuloplasty, aortic valve annuloplasty, and others. The tricuspid valve annuloplasty segment is expected to hold a significant share of the market in the forecast period owing to the rising prevalence of tricuspid regurgitation. For instance, in October 2023, according to Science Direct, the incidence of moderate or severe tricuspid regurgitation (TR) increases with age; the prevalence in the general population reaches 1.5% and 5.6% in men and women, respectively. Tricuspid valve annuloplasty is performed to address conditions such as tricuspid regurgitation (TR), where blood flows back into the right atrium during the heart's contraction. Thus, amongst applications, the tricuspid valve annuloplasty category is expected to witness a higher CAGR during the forecast period.

For a better understanding of the market adoption of annuloplasty rings, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the increasing geriatric population, and rising number of investments in developing effective annuloplasty rings. For instance, according to the Population Reference Bureau, the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase). Government organizations are initiating cardiac disorder awareness programs to provide efficient care to patients. Apart from these, North America has an enormous number of leading medical device manufacturers which is further propelling the growth of the annuloplasty ring market in the region.

Some of the major players operating in the market include Affluent Medical; Corcym; Braile Biomedica; Coroneo; Edwards Lifesciences Corporation; Genesee BioMedical; HVR Cardio Oy; Medtronic; Abbott; Valcare Medical.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

• 1.1.Market Definitions
• 1.2.Main Objective
• 1.3.Stakeholders
• 1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1.Research Process of the Annuloplasty Rings Market
• 2.2.Research Methodology of the Annuloplasty Rings Market
• 2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE ANNULOPLASTY RINGS MARKET

6. ANNULOPLASTY RINGS MARKET REVENUE (USD BN), 2020-2030F

7. MARKET INSIGHTS BY RIGIDITY

• 7.1.Flexible
• 7.2.Rigid
• 7.3.Semi-rigid
• 7.4.Others

8. MARKET INSIGHTS BY APPLICATION

• 8.1.Mitral valve annuloplasty
• 8.2.Tricuspid valve annuloplasty
• 8.3.Aortic valve annuloplasty
• 8.4.Others

9. MARKET INSIGHTS BY REGION

• 9.1.North America
  • 9.1.1.U.S.
  • 9.1.2.Canada
  • 9.1.3.Rest of North America
• 9.2.Europe
  • 9.2.1.Germany
  • 9.2.2.U.K.
  • 9.2.3.France
  • 9.2.4.Italy
  • 9.2.5.Spain
  • 9.2.6.Rest of Europe
• 9.3.Asia-Pacific
  • 9.3.1.China
  • 9.3.2.Japan
  • 9.3.3.India
  • 9.3.4.Rest of Asia-Pacific
• 9.4.Rest of World

10. ANNULOPLASTY RINGS MARKET DYNAMICS

• 10.1.Market Drivers
• 10.2.Market Challenges
• 10.3.Impact Analysis

11. ANNULOPLASTY RINGS MARKET OPPORTUNITIES

12. ANNULOPLASTY RINGS MARKET TRENDS

13. DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1.Demand Side Analysis
• 13.2.Supply Side Analysis

14. VALUE CHAIN ANALYSIS

15. COMPETITIVE SCENARIO

• 15.1.Competitive Landscape
  • 15.1.1.Porters Fiver Forces Analysis

16. COMPANY PROFILED

• 16.1.Affluent Medical
• 16.2.Corcym
• 16.3.Braile Biomedica
• 16.4.Coroneo
• 16.5.Edwards Lifesciences Corporation
• 16.6.Genesee BioMedical
• 16.7.HVR Cardio Oy
• 16.8.Medtronic
• 16.9.Abbott
• 16.10.Valcare Medical

17. DISCLAIMER